Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 135,546 | 144,767 | 129,620 | 127,013 | 123,549 |
| Cost of Goods | 61,720 | 67,365 | 79,831 | 68,174 | 71,185 |
| Gross Profit | 73,826 | 77,402 | 49,789 | 58,839 | 52,364 |
| Operating Expenses | 38,913 | 53,140 | 38,863 | 38,546 | 41,439 |
| Operating Income | 35,633 | 24,627 | 11,757 | 20,467 | 11,110 |
| Interest Expense | 21,863 | 21,427 | 20,575 | 19,046 | 17,761 |
| Other Income | 4,027 | -20,757 | 1,027 | 11 | 5 |
| Pre-tax Income | 17,797 | -17,557 | -7,791 | 1,432 | -6,646 |
| Income Tax | 4,790 | -131 | -592 | 975 | -1,455 |
| Net Income Continuous | 13,007 | -17,426 | -7,199 | 457 | -5,191 |
| Net Income | $13,007 | $-17,426 | $-7,199 | $457 | $-5,191 |
| EPS Basic Total Ops | 0.38 | -0.51 | -0.21 | 0.01 | -0.15 |
| EPS Basic Continuous Ops | 0.38 | -0.51 | -0.21 | 0.01 | -0.15 |
| EPS Diluted Total Ops | 0.34 | -0.51 | -0.21 | 0.01 | -0.15 |
| EPS Diluted Continuous Ops | 0.30 | -0.51 | -0.21 | 0.01 | -0.15 |
| EBITDA(a) | $73,893 | $62,910 | $54,861 | $58,507 | $49,267 |